The World Market for Glycosides, Glands or Other Organs and Extracts, Antisera, Vaccines, and Similar Products Ebook

This report was created for strategic planners, international executives and import/export managers who are concerned with the market for blood-grouping reagents. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for blood-grouping reagents for those countries serving the world market via exports or supplying from various countries via imports. I do so for the current year based on a variety of key historical indicators and econometric models.On the demand side, exporters and strategic planners approaching the world market face a number of questions. Which countries are supplying blood-grouping reagents? What is the dollar value of these imports? How much do the imports of blood-grouping reagents vary from one country to another? Do exporters serving the world market have similar market shares across the importing countries? Which countries supply the most exports of blood-grouping reagents? Which countries are buying their exports? What is the value of these exports and which countries are the largest buyers?In what follows, Chapter 2 begins by summarizing the regional markets for imported and exported blood-grouping reagents. The total level of imports and exports on a worldwide basis, and those for each region, is based on a model which aggregates across over 150 key country markets and projects these to the current year. From there, each country represents a percent of the world market. This market is served from a number of competitive countries of origin. Based on both demand- and supply-side dynamics, market shares by country of origin are then calculated across each country market destination. These shares lead to a volu